Jeerika Diaz
Psychiatric/Mental Health · Orlando, FLNPI 1801482260
Payments from drug & device makers
Across 416 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Axsome Therapeutics, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$845
- Johnson & Johnson$682
- plus $3K from 23 others
What the payments were for
- Food & beverage$10,130100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $2,108 |
| Alkermes, Inc. | 53 | $1,369 |
| Otsuka America Pharmaceutical, Inc. | 51 | $1,229 |
| Axsome Therapeutics, Inc. | 19 | $1,065 |
| Teva Pharmaceuticals USA, Inc. | 27 | $845 |
| Johnson & Johnson | 32 | $682 |
| Vanda Pharmaceuticals Inc. | 21 | $444 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $387 |
| Neurocrine Biosciences, Inc. | 15 | $282 |
| Ironshore Pharmaceuticals Inc. | 17 | $258 |
| Livanova USA, Inc. | 2 | $197 |
| Lundbeck LLC | 10 | $194 |
| E.r. Squibb & Sons, L.L.C. | 5 | $189 |
| Sunovion Pharmaceuticals Inc. | 12 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $127 |
| Boehringer Ingelheim | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $97 |
| Idorsia Pharmaceuticals US Inc | 5 | $88 |
| Biogen | 4 | $76 |
| Tris Pharma Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $31 |
| Amgen | 1 | $22 |
| Almatica Pharma LLC | 1 | $19 |
| Indivior Inc. | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| Merck | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,057
- Auvelity$743
- LYBALVI$428
- AUSTEDO$272
- ARISTADA INITIO$264
- VRAYLAR$234
- ABILIFY MAINTENA$223
- Austedo XR$220
- COBENFY$126
- CAPLYTA$124
- UBRELVY$124
- VNS Therapy Symmetry Model 8103 Generator$120
- UZEDY$114
- INVEGA SUSTENNA$113
- INVEGA TRINZA$113
- REXULTI$108
How this compares
$10,130 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 138 | $193,407 |
| TrintellixVortioxetine Hydrobromide | 160 | $78,661 |
| LybalviOlanzapine/Samidorphan Malate | 33 | $50,814 |
| QuviviqDaridorexant Hcl | 77 | $38,274 |
| Invega SustennaPaliperidone Palmitate | 11 | $36,520 |
| Lurasidone Hcl | 37 | $22,436 |
| RexultiBrexpiprazole | 15 | $21,156 |
| BelsomraSuvorexant | 38 | $16,054 |
| Buspirone Hcl | 429 | $5,811 |
| Aripiprazole | 90 | $4,542 |
| Doxepin Hcl | 36 | $4,219 |
| Duloxetine Hcl | 163 | $3,520 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 25 | $3,383 |
| Quetiapine Fumarate | 221 | $2,401 |
| Bupropion XlBupropion Hcl | 181 | $2,284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,108 | $193,407138 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $127 | $78,661160 claims |
| Alkermes, Inc.Lybalvi | $1,369 | $50,81433 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $88 | $38,27477 claims |
| Johnson & JohnsonInvega Sustenna | $682 | $36,52011 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,229 | $21,15615 claims |
| MerckBelsomra | $14 | $16,05438 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $1,352324 claims |
| Lilly USA, LLCOlanzapine | $31 | $66434 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.